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Control of Growth and Squamous
Differentiation in Normal Human Bronchial
Epithelial Cells by Chemical and Biological
Modifiers and Transferred Genes
by Andrea M. A. Pfeifer,* John F. Lechner,* Tohru Masui,*
Roger R. Reddel,* George E. Mark,* and Curtis C. Harris*
Themajority ofhuman lungcancers arise from bronchial epithelial cells. The normal pseudostratified bron-
chial epithelium is composed ofbasal, mucous, and ciliated cells. This multidifferentiated epithelium usually
responds to xenobiotics and physical injury by undergoing basal cell hyperplasia, mucous cell hyperplasia,
and squamous metaplasia. One stepofthe multistage process ofcarcinogenesis is thoughtto involve aberra-
tions in control ofthe squamous metaplastic processes. Decreased responsiveness to regulators ofterminal
squamous differentiation may confer aselective clonal expansion advantage to an initiated cell. We studied
the effects ofendogenous [e.g., transforming growthfactorPI (TGF-pi) and serum] andexogenous [e.g., 12-0-
tetradecanoyl-13-phorbolacetate (TPA), tobacco smoke condensate, and aldehydes] modifiers ofnormal hu-
man bronchial epithelial (NHBE) cell in a serum-free culture system. NHBE cells are growth inhibited by
all ofthese compounds andinducedtoundergo squamous differentiation byTGF-PI orTPA. In contrast, lung
carcinomacell lines arerelativelyresistanttoinducers ofterminal squamousdifferentiation which mayprovide
them with a selective growth advantage. Chemical agents and activated protooncogenes (rs,ratfmyc) altered
the response toendogenousandexogenous inducers ofsquamous differentiation and caused extended cellu-
lar lifespan, aneuploidy, and/or tumorigenicity. The data suggest aclose relationship between dysregulation
ofterminal differentiation pathways and neoplastic transformation of human bronchial epithelial cells.
Introduction
Proliferation andterminal differentiation ofnormal cells
are usually controlled by different signal transduction
pathways. The interactions of these two controlling
mechanisms ensure the homeostatic balance between cell
proliferation and terminal differentiation. Uncoupling of
the normal balance between the two interacting systems
due to eithergenetic orepigenetic changes isthought to
be a critical step in the generation and further progres-
sion ofamalignant cellphenotype. It hasbeen suggested
that squamous metaplasia and dysplasia play an impor-
tant role in lining epithelial cell transformation and that
preneoplastic cells acquire a selective resistance to in-
ducers ofdifferentiation because the controllingpathways
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forthe terminal aspects ofthis cellularprocess are defec-
tive. As a consequence, theymayhave aclonalgrowth ad-
vantage over normal cells (1-4) and, in agreement with
this hypothesis, diminished response to inducers of
differentiation is a common characteristic ofcarcinomas
(1,5-11).
Constitutive production ofmitogens (autocrine growth
control) (12,13), reduced or ablated dependence on para-
crine growth factors, selective resistance to cytotoxic
agents, as well as escapefrom cell-cell communication, are
other conceivable aberrations thatmaygenerate selective
clonal expansion ofpreneoplastic andneoplastic cells. To
gain an understanding ofmechanisms involved in human
carcinogenesis, itis critical to analyzethe interactions of
the multiple pathways controllinggrowth and differenti-
ation oftheepithelial cells. Inthisreview, wewill discuss
the use ofcultured human bronchial epithelial cells as a
model system to investigate the molecular and cellular
mechanisms controlling growth and differentiation of
epithelial cells.PFEIFER ETAL.
Activated proto-oncogenes that have been associated
with lung cancer include the ras, myc, ard raffamilies
(14-18), and transfected oncogenes have been shown to
transform normal human epithelial cells (19). Very re-
cently, wehave isolated aSV40T-antigen containingbron-
chial epithelial cell culture that has an indefinite lifespan
(20)butretains the ability torespond to certain inducers
of squamous differentiation (21). Because the differential
response ofnormal andtransformed epithelial cells to in-
ducers of differentiation can be employed to determine
aberrationsoftumorcells inpathways controllingprolifer-
ation (5,7-10), we will also review the changes in the
differentiation program causedby transfected oncogenes.
Serum-Free Culture System for
NHBE Cells
Serum-free culture systems have been developedforhu-
man and mouse keratinocytes (22-24) and for normal
(25-27)andneoplastic epithelial cells (28-30). Serum-free
media permit studies ofindividual elements controlling
growth anddifferentiation in awell-characterized environ-
ment. The application of serum-free media identified
other components that had been masked by serum sup-
plementation in culture medium and allowed the growth
of some cell types that cannot be duplicated in conven-
tional, serum-containingmedia. In our system, serum was
found to inhibit growth of normal human bronchial
epithelial (NHBE) cells by inducing terminal squamous
differentiation (7,25,31). Therefore, our studies have been
performed using a serum-free culture system developed
from medium MCDB 151, optimized for osmolarity and
[Ca2 ]+ , and supplemented with insulin (5 ,ug/mL),
epithelialgrowthfactor(EGF)(5 ng/mL), transferrin (10
pg/mL), hydrocortisone (0.2XM), bovine pituitary extract,
gentamicin (50 pg/mL), and trace elements (25).
Endogenous Inducers of Squamous
Differentiation of NHBE Cells
Although most carcinogenesis studies have been fo-
cused on the activation of proliferative responses by
growth factors and oncogenes, it is equally important to
analyze defects in mechanisms regulating terminal
differentiation. In agreement, the diminished response to
inducers of terminal differentiation is a phenotypic in
vitro marker of neoplastic epithelial cells (6-8,11,32).
Bronchial epithelial cells undergo several types of
differentiation, i.e., ciliary, mucous, and squamous. Squa-
mous differentiation is characterized by squamous mor-
phology, irreversible cessation ofDNA synthesis and cell
division, continued RNA synthesis (for 3 days), formation
ofcross-linked envelopes (CLE), and enhanced release of
plasminogen activator (PA).
TGF-pl Induces Squamous Differentiation
Transforming growth factor (TGF-p1) expression and
TGF-p1-specific receptors have been detected in avariety
of normal and tumor cells (33-36). The cellular effects
reported for TGF-f31 are very complex (37). TGF-f31 is
growthinhibitoryfornormal and certain epithelialtumor
cell lines (38-40), stimulates proliferation of fibroblasts
(41), but also exhibits differential effects on proliferation
ofnormal andmalignant cells(42,43). Aberrations in path-
ways controlled by TGF-f31 in a negative manner can be
expected to cause uncontrolled cell proliferation.
In our model system, insulin, EGF, retinoic acid, unde-
fined pituitary extract constituents, and epinephrine
stimulate cell multiplication (25), whereas serum, high
concentration of extracellular Ca2", and TGF-p1 are in-
ducers of terminal squamous differentiation of NHBE
cells (Table 1)(7,25,42).TGF-f31 inhibits the clonalgrowth
rate and DNA synthesis of NHBE cells in a dose-
dependent manner, i.e., 4 pM TGF-p1 causes arapid 95%
inhibition of DNA synthesis, but RNA synthesis re-
mained at near normal rates for 3 days (42). The DNA
synthesis inhibition is irreversible and accompanied by an
increase of CLE, PA release, and cell surface area. The
IgGfraction ofrabbit TGF-fl1 antiserumneutralizes both
the inhibition ofDNA synthesis causedby TGF-p1 or se-
rum and suppressed the squamous morphology. The data
implied that TGF-p1 is an important differentiation-
inducing serum factor in NHBE cells. Similar findings
have been reported forrat hepatocytes (44), mouse orhu-
man epiderminal keratinocytes (24,45), and rabbit
tracheal epithelial cells (46,47).
Inaddition, thelatentform ofTGF-p1 is detected in con-
ditioned medium ofNHBE cultures(48). Theisolation of
a TGF-p1 binding protein (a2M) in serum has led to the
speculation that secretedTGF-p1 is protected by forma-
tion of aTGF-pi-protein complex and released at target
sites (49). However, the precise activation mechanism of
the latentform ofTGF-p3 is notknown. Furthermore, the
induction ofsquamous differentiation by TGF-p1 and se-
rum is a density-dependent process andhighdensity cul-
Table 1. Endogenous and exogenous modifiers and
their effects on growth and differentiation of
NHBE cells.
Modifier Growtha Differentiationa
Endogenous agents
Insulin I NE
EGF I NE
Pituitary extract ib NE
Epinephrine ib D
Retinoic acid I NE
Ca2 + IC Id
TGF-pi D I
Serum D I
Exogenous agents
TPA D I
Teleociden B D I
Cigarette smoke D I
condensate
Aldehydes D I
a I, increase; D, decrease; NE, no effect.
b Only in presence of EGF.
c In low density culture.
d In confluent cultures.
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tures ofNHBE cells, i.e., > 11,000 cells/cm2 I
face, are more resistant to eitheragent(J. F. I
A. M. A. Pfeifer, unpublished observation). TI
the presence of a putative endogenous fact(
characterized by antagonism to TGF-fl( or s
present in a sufficient amount only in high
tures (Fig. 1).
The Role of Ca2+ in Controlling S
Differentiation ofNHBE Cells
The role ofCa2+ in regulating epithelial c
tion and differentiation has been delineated*
of systems. Rat tracheal epithelial cells (50)
keratinocytes (51) show maximal growth at
0.3 mM Ca2+, respectively. Mousekeratinoc3
man mammary epithelial cells(53), andvarioi
rine and human cells proliferate in low Ca2
mM) (54) and undergo terminal differential Ca2+.
Inexperinents comparing clonal andhigh
tures ofNHBE cells in serum-free medium,
extracellular Ca2+ is dependent on the nun
per square centimeter. Up to 1 mM Ca2+ is
inhibiting atclonal density (25), whereashigh
tures (> 11,000 cells/cm ) are induced to un
mous differentiationby0.3mM Ca2+ andabo'
squamous differentiation of clonal density
NHBE cells can be induced by Ca2+ in the
complementary undefined factors. Thus, in
with low amounts of fetal bovine serum (1.
causes clonal density cultures ofNHBE cellh
squamous differentiation in a dose-depend
(Fig. 1) (31). The divergent findings in low
density cultures are consistent with the hyp
NHBE cells produce a differentiation-in
togenous factor that accumulates to an effec
trationonlyinhigh density culturesandis co]
* Squamous Differentiation
Induction: M Autogenous Factors
* Serum
* TGF (
* TPA
G2 M
Inhibition: 0 High Density
Culture Factors
O Epinephrine
O Retinoic Acid
Do,
0 Dl 0
Phenotype: * Squamous
Morphology
* Inhibition of
DNA Synthesis
* Decrease in
c-myc mRNA
* Induction of
c-fos mRNA
FIGURE 1. Model ofthe multistage squamous different
bronchial epithelial cells. Cells atDo or D1 (nontermi
ation state) can re-enter proliferation or undergo te
tiation (Dt). Ca2 + induces Dt only in the presence
togenous factors expressed at cell confluence.
culture sur-
jechnerand
his suggests
or(s) that is
erum and is
density cul-
quamous
ell prolifera-
in anumber
and human
0.8 mM and
ytes(52), hu-
as othermu-
+ (0.03-0.07
tion in high
density cul-
by extracellular Ca2 . The synergistic effect ofCa2+ sug-
gests either anincreased release ofthe factor or an acti-
vation of the factor by Ca2 .
Recently, we investigated the question ofwhether the
effectofdifferentiationinducers, [e.g.,TGF-p1, serum, or
12-0-tetradecanoyl-13-phorbolacetate (TPA) is mediated
by an increase offree cytosolic calcium ion ([Ca2+]s), em-
ploying afluorescence assay with fura-2. Fura-2 forms a
fluorescent calcium complex and the emitted flourescence
at510nmiscalciumion-concentration dependent(55). We
found that serum caused a2-fold enhancement of[Ca2 +]
flux into the cytosol, whereas neither T&GF-P, nor TPA
changed cytosolic[Ca2+]i concentration (55). Thus, early
and rapid changes in intracellular [Ca2+]i are not abso-
lutelyrequiredforthe cellsin orderto undergo squamous
differentiation.
Squamous Differentiation Induction
by TPA and Its Possible Mechanism
the effect of The effects of TPA in the mouse skin carcinogenesis
nber of cells model suggestthattwo differentclassesofcompounds(in-
not growth- itiators and promoters) are involved in oncogenesis and
densitycul- further, that carcinogenesisis amultistep process(2). In
idergo squa- addition to theirpromotingactivity onmouse epidermis,
ve However, certainphorbolestershavemultipleeffectsongrowthand
cultures of squamous differentiation ofcells in vitro. In most types
presence of of epithelial cells, the predominant response to TPA is
combination growth inhibition and/or differentiation (56-60), whereas
.25%), Ca2+ some fibroblast systems are mitotically stimulated by
stoundergo TPA (61,62).
Ient manner Despite their different chemical structures, the tumor
versus high promoters TPA, teleocidin B(indolalkaloid), aplysiatoxin,
iothesis that debromoplysiatoxin, andhydrogen andbenzoylperoxides
iducing au- induce terminal squamous differentiation ofNHBE cells
,tive concen- (59,63,64). There is evidence from other systems thatthe
mplemented induction ofsquamous differentiation byTPAandrelated
compounds ismediatedbythe direct activation ofprotein
kinase C (65,66), which is the specific membrane recep-
torforTPA(67)andteleocidin B(68). Inhumankeratino-
cytes, TPA causes terminal squamous differentiation
(56,57,69), and the event is dissociated from the TPA-
* lCa2+J>1mM induced phospholipase A2 activation, including the sub-
sequent release of arachidonic acid and induction of
prostaglandin synthesis (70). The biosynthesis of
prostaglandins and hydroxyarachidonic acid involves the
Dt intermediate formationofunstablehydroxyperoxy deriva-
* Squamous tives and concomitant release of active oxygen (71). Morphology Generationofactive oxygen speciesleadingtolipidperox-
* Spontaneous idationandrelease ofcalciumionintothe cytosolhasbeen rossLnked describedfortumorpromoters, i.e., TPA, benzoyl perox-
* Irreversible ide, andhydrogenperoxide (71). We havefound, however, lnhibitionof that the induction ofsquamous differentiation ofNHBE CellDnivon cells by TPA does not involve free oxygen radicals (72).
* lnvolucnn Thus, the activation ofphospholipase A2 andlipidperox-
iation ofhuman idation arepresumably notessentialforthiseffectofTPA inallydfferenti- on NHBE cells. This is consistent with our observation
of serum or au- that free cytosolic[Ca +]i is unaltered after exposure of
NHBE cells to TPA(55). Moreover, TPApretreatment of
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NHBE cells resulted in a diminished [Ca2+]iresponse in-
duced by serum(55). However, benzoylperoxide orhydro-
genperoxide do notbindtoprotein kinase C(73)and are
potent inducers oflipidperoxidation associated with the
disturbance of[Ca2+]i homeostasis (71). Therefore, lipid
peroxidation may play a role for this class of tumor
promoters. In conclusion, various types of tumor
promoters induce squamous differentiation of NHBE
cells by different mechanisms of action.
Cigarette Smoke Condensate Induces
Features ofTerminal Squamous
Differentiation
Because tobacco smoke is the major cause oflung can-
cer, we have been studying the effects oftobacco smoke
and its components on growth and differentiation of
NHBE cells (74). The effects ofwhole tobacco smoke con-
densate and individual fractions on clonal growth rate,
plasminogen activity, CLE formation, ornithine decarbox-
ylase activity (ODC), EGF binding, thiol depletion and
DNA single strand breaks (SSB) (75) have been inves-
tigated. Cigarette smoke condensate(CSC), thetwobasic
fractions (Bla and Blb), the weakly acidic fraction (WAe),
andtheneutralmethanolfraction(Nmeoh)aregrowthin-
hibitory and induce CLE formation and squamous mor-
phology. Neither CSC nor any of the fractions signifi-
cantly affect intracellular thiol levels or ODC activity.
DNA SSB were detected with 100 ,ug/mL CSC and low
concentrations ofNmeoh(5,ug/mL). Plasminogen activa-
torwas increased by Nmeohonly. CSC,WAeand Nmeoh
caused a decrease in EGF binding that was primarily
related to a diminished EGF receptor affinity (75).
Because TPA neutralizes the growth stimulation in-
ducedby EGF inprostaticepithelial cells(76)andinduces
markers ofdifferentiation in NHBE cells (59), we inves-
tigated the possibility of CSC and particularly Nmeoh
having a TPA-like effect on growth of NHBE cells. CSC
or Nmeoh, but not Bla or Blb, inhibited the binding of
phorbol dibutyrate to a small degree (77), indicating the
presence ofalowconcentration ofTPA-relatedcompounds
in CSC and that the majority oftumor promoting com-
ponents in CSC are different fromTPA. However, subse-
quently, we have found that TPA induces interleukin-1
mRNA synthesis in NHBE cells but CSC does not, con-
firmingthe suggestion that the concentration ofTPA-like
substances in CSC mustbe extremely low(B. Gerwin and
M. Miyashita, unpublished data).
Effects ofTobacco Smoke-Related
Aldehydes on Squamous Differentiation of
NHBE Cells
As aldehydes have been found in the gaseous phase of
tobacco smoke and are mutagenic (78), cytotoxic (79,80),
andtumorpromoting, we have been studyingthe effects
ofvariousaldehydes ongrowth and differentiation ofcul-
tured bronchial epithelium(78). Clonalgrowthrate, squa-
mous differentiation, DNA damage, DNA synthesis,
arachidonic acid and choline release, the activity ofaryl
hydrocarbon hydroxylase (AHH), and ODC were mea-
sured. Formaldehyde, acetaldehyde, and acrolein inhibit
growth and induce CLE formation (Tible 1) (63,80), but
only acetaldehyde increases squamous morphology
(78,79). Formaldehyde causes DNAsingle strandbreaks
and DNA-protein cross-links and dramatically enhances
ODC activity. The inhibitory effect of formaldehyde or
acetaldehyde onAHH, DNAand RNA synthesis, aswell
asthereleaseofarachidonicacidandcholineissimilarfor
bothcompounds. Thus, aldehydeshave complexeffectson
NHBE cells and share with TPA and serum the ability
to increase the number of CLE-competent cells.
Thiollevels are decreased in NHBE cells and cultured
human bronchial fibroblasts following the exposure to
acrolein, whereas formaldehyde and acetaldehyde are
muchless effective (78,80). Since the depletion ofGSH by
acrolein is not correlated with an increase in GSSG (81),
thegeneration ofradicals and subsequent lipidperoxida-
tion may notplay arole for effects ofaldehydes on squa-
mous differentiation ofNHBE cells. However, it ispossi-
ble thatfree cytosolic[Ca2+]iis involved in the induction
of CLE formation because aldehydes increase the cyto-
solic [Ca2+I concentration (82) and CLE formation is a
Ca2+-dependent mechanism (83).
Differential Response of Lung
Carcinoma Cells to Inducers of
Squamous Differentiation
Resistance to inducers of terminal differentiation has
been identified as a common marker for malignant cells.
For example, only transformed mouse keratinocytes
formed foci of cells resistant to high extracellular Ca2+
in culture, and the number offoci is elevatedby TPA (1).
This observation is consistent with the theory that ini-
tiated cells are selectively resistantto terminal differen-
tiationby tumorpromoters and thus, acquire a selective
clonal growth advantage (1,2). Similar effects have been
reported for mouse keratinocytes initiated in vivo or in
vitro with 7,12-dimethylbenz(a)anthracene or N-methyl-
N'-nitro-N-nitrosoguanidine (84) and for rat liver cells
transformedinvitrobyaflatoxinB1 whichbecomeresis-
tant to extracellular Ca2+ andTGF-P1, respectively (43).
We examined the responsiveness ofseveral lung carci-
nomacelllines ofdifferent histopathology(A549, Calu 1,
Hut292)to inducers ofterminal squamous differentiation
in NHBE cells. None ofthe tumor cell lines underwent
squamous differentiation induced by serum (7,48), TGF-
P3i (42), or TPA (64). Moreover, lung carcinoma cell lines
are growthinhibited in serum-free medium, and growth
is stimulatedby serum, indicatingthattheyacquiredthe
abilitytorespondtounidentifiedgrowthfactors in serum.
In addition, CSC oritsfractions didnot cause significant
morphological changesincarcinomacelllines(77)toward
a squamous differentiated phenotype. The resistance of
tumorcelllines toinducersofterminalsquamous differen-
tiationisnotdue to detectable changes inTPAmembrane
receptors (42). Assays analyzing the properties of the
TGF-pf-specific receptors showed no significant differ-
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ences for A549 and Calu 1 compared to NHBE cells,
whereas a third line, Hut 292, possessed a smaller num-
berofreceptors withhigh affinitytoTGF-P1 (42,85). The
differential response of the carcinoma cell lines to in-
ducers of differentiation implies the selective clonal ex-
pansion advantage ofneoplastic cellsgenerated by an im-
balance between growth- and differentiation-controlling
pathways.
Role of cAMP in Squamous
Differentiation of NHBE Cells
We have identified several endogenous and exogenous
inducers ofsquamous differentiation in NHBE cells, and
it wastemptingto searchforacommonmediatorintheir
pathways. We previously reportedthat thegrowthrate of
NHBE cells is enhanced by epinephrine or other cAMP
enhancers, i.e., 3-isobutyl-1-methyl-xanthine, dibutyryl
AMP, and cholera toxin, in the presence ofEGF and pi-
tuitary extract (86). The growth stimulation is accompa-
nied by an increase of cAMP and ODC activity (86,87),
however, elevated ODC activity isnecessary but not suffi-
cient for stimulation ofNHBE growth(86). The effect of
cAMP can either result in stimulation or reduction of
proliferation in epithelial cells dependingon the location
of cAMP synthesis in the cell and the type of cAMP-
dependent protein kinase present (88).
In our system, cholera toxin, a stimulator ofintracellu-
larcAMP, antagonizestheinduction ofterminal squamous
differentiation by serum (48), which indicates anegative
correlation between cAMP content and induction of
differentiation. To test this hypothesis, we examined the
effect ofepinephrine, choleratoxin, andpertussis toxin on
growth of NHBE cells exposed to TGF-p1. We showed
that epinephrine neutralizes the effect ofTGF-P1 (Table
1)(42), whereasgrowth stimulation causedbyepinephrine
is antagonized byTGF-p1. Thus, epinephrine andTGF-P1
aremutuallyantagonistic. Theepinephrine effectis asso-
ciated with anincrease incAMP, butTGF-P1 antagonizes
epinephrine without altering intracellular cAMP levels.
The antagonism between TGF-P1 and epinephrine does
not involve changes at the receptor level, as the charac-
teristics of the TGF-P1 receptor are unaltered by
epinephrine (36). Therefore, the antagonism ofTGF-pi1,
andepinephrine does notreflect a commonpathway. Itis
morelikelythatthesecompoundsaffectdifferentmechan-
isms implicated in control ofgrowth and differentiation
ofNHBE cells. However, since epinephrine alsopartially
antagonizes TPA(T. Masui, unpublished results), TGF-p1
andTPApathways to squamous differentiation seemingly
converge prior to passing beyond the irreversible step.
Functions of c-myc, c-fos, and
c-Ha-ras Protooncogenes in the
Differentiation Process of NHBE
Cells
Tb date, more than 30 oncogenes have been identified
andassociated withanimal orhumantumors(89,90). The
nonnal cellular homologues (protooncogenes) are charac-
terizedby unique features suggestingan essential phys-
iological role of these genes in the regulation of cell
proliferationand differentiation: a)protooncogenes have
been highly conserved through evolution; b) the gene
products are specificallylocatedinthenucleus, cytoplasm,
orbound to the plasmamembrane; c) the corresponding
proteins exhibit distinctive functional activities; and d)
several protooncogenes resemble growth factors or
growth factor receptors (91-94). The fact that protoon-
cogenes are differentially expressed during embryogen-
esis(95) and show stage-specific expression duringhuman
monocyte differentiation (96)also suggests aroleforthese
cellulargenes ininductionofdifferentiation. Alongthese
lines, c-src expression has been mostly correlated with
differentiation ofneuronal cells, c-fos with hematopoietic
differentiation, and c-fmn withmacrophage differentiation
(97). The expression ofc-myc andc-myb isnegatively cor-
related to erythroid and neuronal differentiation and is
dependent on the cell lineage and on the differentiation
stage (97). Moreover, c-ras proteins are presumably in-
volved in differentiation of various cell types (98,99).
Weinvestigatedtheassociationofc-fos,c-myc, andc-Ha-
ras genes with differentiation ofNHBE cells employing
TGF-P1 or TPA as differentiation-inducing agents and
epinephrine as an antagonizer of TGF-p1. c-fos mRNA
steady-state levels are increased 2-fold within 1 hr after
TGF-P1 exposure and came back to normal after 3 hr (T.
Masui, unpublished observations). The simultaneous ap-
plication ofTGF-(31 and epinephrine caused up to 5-fold
induction ofc-fos mRNA after 1 hr. In contrast to c-fos,
c-Ha-ras mRNA steady-state levelswere hardly affected
byITF-p1; c-myc mRNA decreased in a dose-dependent
manner to 40 to 80% ofthe original value. The effect on
c-myc mRNA was transient for low concentrations of
TGF-p1, butresulted inanirreversible reduction ofc-myc
mRNA at a highTGF-P1 dose (100 pg/mg). Epinephrine
neutralizedthe effectofTGF-P, onc-mycexpression. TPA
caused the same pattern of changes in protooncogene
mRNA steady-state levels characterized by an increase
ofc-fos, no change ofc-Ha-ras, and a reduction in c-myc
during the first hour.
Based onourexperiments, we cannot discriminate ifthe
c-fos induction is a causative event for differentiation or
ifitsfunction is only signaltransduction. However, since
epinephrine inhibits terminal squamous differentiation of
NHBE cellsbyTGF-p1, but induces synergistically c-fos
mRNA, thec-fos signal appears tobe associatedwith sig-
nal transduction rather than induction of squamous
differentiation per se. In accordance, two important cel-
lular signal transduction pathways, the protein kinase
C/Ca2+ andthe cAMP system, havebeenassociated with
c-fos induction(100-102). In PC 12 cells, cAMP or activa-
tion oftheproteinkinase C (PKC)accompaniedbythe in-
crease offree cytosolic[Ca2+], cause arapidinduction of
c-fos mRNA (101). However, c-fos is stimulated in fibro-
blasts by the PKC/Ca2+ system but not by cyclic purine
nucleotides (102). Aspreviously discussedinthisreview,
neitherTGF-P1 nor TPA alter the free cytosolic [Ca2+],
concentration in NHBE cells, and cAMPlevels are not af-
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fected byTGF-p1, suggesting the involvement ofanother
pathway, orpathways, which are not controlled by either
free cytosolic [Ca2+]I or cAMP.
An inverse correlation of c-myc, N-myc, or c-myb ex-
pression has been documented during HL 60 differenti-
ation(97), duringinvitro differentiation ofneuroblastoma
cell lines (103), and during induction ofdifferentiation of
F9 teratocarcinoma cells, respectively (104). c-myc has
been implicated in the regulation ofcellularproliferation,
and downregulation of c-myc mRNA may be a conse-
quence for or may trigger differentiation in certain cell
systems (105).
The irreversible downregulation of c-myc mRNA in
NHBE cellsexposed tohighlevelsofTGF-P1 supportsthe
first mechanism but cannot exclude a function of the c-
myc gene formediating differentiation signals. However,
since epinephrine neutralizes the effects ofTGF-P1 on in-
hibition of growth, as well as on c-myc expression, the
reduction in c-myc expression mayrepresent only ablock-
age ofproliferation ratherthan adifferentiation-inducing
signal.
In conclusion, alterations in the expression ofc-myc, c-
fos, and c-Ha-ras occurparallel with the induction ofsqua-
mous differentiation in NHBE cells. The findings to date
imply afunction ofthese protooncogenes in signal trans-
duction rather than in signal induction. Further studies
on protooncogene expression under the influence of
agents antagonizing terminal squamous differentiation
are required to determine the precise role ofthese genes.
Transfection experiments in which c-fos, c-myc, and c-Ha-
ras sequences arebeingintroducedinto normal orimmor-
talized humanbronchial epithelial cells will provide addi-
tional information on the role ofthese protooncogenes in
induction of squamous differentiation.
Carcinogenesis Studies on NHBE
Cells with Nickel Sulfate
Inhalation ofnickel compounds has been implicated in
an increased human risk ofrespiratory cancer(106), and
nickel sulfate has been shown to induce transformation of
rodent cells (107). We tested the chronic effects ofnickel
sulfate on NHBE cells by exposing cultures for 40 days
to a dose of5 to 20mg/mL nickel sulfate. These nickel sul-
fate concentrations resulted in a reduction ofthe colony-
forming efficiency by 30 to 80% (108). After 40 days, mi-
toses figures appeared, and, after 75 days total incubation
time, 1 focus per 105 cells originally inoculated arose in
dishes treated with more than 5 pg/mL nickel sulfate.
Most ofthe cell culturesproducedestablishedfromnickel
sulfate-transformed cells displayed increasedpopulation
doublings andexpressed characteristics ofmalignant cells
in a heterogeneous manner: a) loss of sensitivity to the
squamous differentiation-inducing effect ofserum orTPA;
b) loss ofrequirement of EGF for clonal growth; and c)
aneuploidy and marker chromosomes.
In contrast to results reported on rodent cells (107),
none ofthe nickel-transformed cell cultures was tumori-
genic uponinjection into athymic nudemice norlosttheir
anchorage dependencyforgrowth. Studies onnormal hu-
man fetal kidney epithelial cells showed that nickel sul-
fate inducestransformation ofthese cells resultingin im-
mortalization, anchorage independent growth and chro-
mosomal aberrations. However, thepresence ofthe v-Ha-
ras gene is required for the expression of a fully malig-
nant phenotype (A. Haugen, unpublished observation).
Experiments are in progress to test the possibility that
a second event, i.e., introduction ofSV40 T-antigen gene
can confer tumorigenicity to the phenotypically altered
bronchial epithelial cells.
Immortalization of NHBE Cells with
SV40 T-Antigen Genes
We have shown the usefulness of human bronchial
epithelial cells for investigating mechanisms involved in
growth and differentiation, and the effects ofcarcinogens
andtumorpromoters. However, multistagebronchial car-
cinogenesis studies were limitedby the finite lifespan of
NHBE cells. Therefore, it was one of our priorities to
generate continuously growing cell lines. Other human
epithelial cell types, i.e., epidermal keratinocytes, pros-
tate, colon,bladder, have beenpreviouslyimmortalizedby
SV40 genes employing virus infection or calcium phos-
phate transfection (109). However, NHBE celis are killed
by calcium phosphate. These effects could be circum-
vented by developing a new transfection technique in
which strontium phosphate substitutes for the calcium
divalent ion (110).
In anattempt to extendthe lifespan ofprimary NHBE
cultures, we transfected NHBE cells via strontiumphos-
phate precipitation with a recombinant plasmid (pSV-T)
containingthe SV40large T-antigengene (BET), orby in-
fection with either SV40 virus (BES) or an adenovirus
12/SV40 hybrid virus (BEAS) (20). Several colonies of
morphological transformedcellswere isolatedandcharac-
terized (Table 2). The lifespan of the SV40-transformed
cells was extended by a minimum of20 population dou-
blings compared to NHBE cells, but all except one ofthe
strains eventually underwent crisis; some subsequently
became established as continuously growing cell lines.
The celllinestestedretainedepithelialfeaturesbasedon
electron microscopy and keratin staining but were
aneuploid and expressed SV40T-antigenmeasuredbyin-
direct immunofluorescence.
These various immoralized cultures were tested for
tumorigenicity in nude mice. BEAS-2B revealed a very
lowtumorigenicpotential afterextendedpassaging. Some
ofthe SV40-transformed clonesretained the capability of
NHBE cells to undergo squamous differentiation in re-
sponse to serum orTGF-P1, but all lost theirresponsive-
ness to TPA. Subclones ofBEAS-2B cellswere obtained
that were either responsive or resistant to the differen-
tiation, inducing effect of serum. These phenotypically
very different subelones andtheuniform resistance to the
differentiation-inducing effect ofTPAprovide an excellent
in vitro model for delineating the mechanisms ofhuman
bronchial differentiation. The apparently unlimited
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Table 2. Establishment oftransformed human bronchial epithelial cell cultures containing SV40 early region genes.
Method of Colonies Number of Crisis before
Designation transformation subcultured established lines establishment
BEAS Ad 12-SV40 virus 2 1 No
BES SV40 virus 3 2 Yes
BET RSV-T plasmid, Exp. 1 1 1 Yes
Exp. 2 3 1 Yes
lifespan and the low tumorigenic potential of these
SV40-transfected human bronchial epithelial cell lines
present themasasuitable systemto study themultistage
bronchial carcinogenesis.
Transformation ofNHBE Cells with
v-Ha-ras and the Combination ofthe
Oncogenes rafand myc
Three families of oncogenes, ras, myc, and raf, have
been associatedwith humanlungcancer. Oncogenes most
frequently detected in human tumors belongto members
ofthe ras gene family (Ha-, Ki-, and N-ras) (111,112). In
approximately 40% ofthe investigated colontumors and
50% ofthe tested adenocarcinomas ofthe lung, activated
Ki-ras with point mutations in codon 12 was found
(17,113). Activation ofras oncogenes have also been de-
tectedinlung cancer cell lines ofnonsmall-cell origin, and
Ki-ras was the predominant activated gene (114).
Elevated levels ofras mRNA have mainly been encoun-
tered in squamous cell carcinomas and were normal in
adenocarcinomas and small cell lung carcinomas tested
(115). In contrast, the myc family (c-myc, N-myc, or L-
myc) is commonly activated in small-cell carinoma cell
lines, and amplification ofmychas alsobeen identified in
fresh tumortissue (15,16,18,116). However, acorrelation
between amplification ofc-myc orN-myc andthe appear-
ance of a variant progressively growing phenotype has
only been found in SCLC lines but not in the original
tumors (16,18,116).
c-raf-1 is the cellular homolog ofthe viral oncogene v-
raf(117) and is frequently present in normal and tumor
cells ofneuronal and hematopoietic origin (118-120). Ac-
tivation ofc-raf-i hasbeen implicated invarious types of
human tumors including gastric carcinoma (121), laryn-
geal carcinoma(122), renal cell carcinoma(123), and alung
carcinoid (124). In addition, overexpression of c-rafhas
beenfoundin small celllungcarcinoma celllinesthathave
acharacteristic deletion onthe short armofchromosome
3 (p14-23) adjacent to the location ofthe rafgene (3p25)
(125).
To determine ifraf, myc, orras sequences mayplay an
important role in human lung carcinogenesis, we in-
troduced these oncogenes into NHBE cells. The initial
study was performed with v-Ha-ras (plasmid H1) using
a protoplast fusion technique (19). Under the selective
pressure of2% serum andmaintenance ofthe cultures at
confluency, four cellular foci appeared. One of them
(TBE-1) was further selected in soft agar leading to
TBE-1SA cell line. TBE-1 and TBE-1SA were injected
into nude mice and caused tumors with alatency of7 to
12 and 2 months, respectively. The progression of
TBE-1SA in malignancy occurred concurrently with de-
velopment ofprogressively abnormal karyotypes includ-
inganeuploidy, gaps, breaks, andexchanges(19), suggest-
ingthat v-Ha-ras maycause chromosomal abnormalities
that lead to secondary alteration ofother loci. However,
increased expression ofother oncogenes, i.e., Ha-ras, N-
myc, c-myc, and c-raf, was not detected. TBE-1 and
TBE-1SA acquired ageneral resistance to differentiation
inducers, i.e., serum andTPA, indicatinganimbalance in
their growth and differentiation program.
We have also transfected NHBE cells with the gene
from aBurkitt'slymphomacellline(B-myc)byprotoplast
fushion technique. The B-myc transfected cells were
selected in4% serum orTPA(10nM) and showed a5-fold
increase inthe frequency ofdifferentiation-resistant colo-
nies compared to the control. The cells of the resistant
colonies had a finite lifespan. Therefore, an SV40 T-
antigenimmortalized cellline(BEAS-2B)appeared tobe
amore suitable recipient to studythe effects ofoncogenes
in NHBE cells. The introduction ofthe lungcancer-asso-
ciatedoncogenes ras, myc, andrafwasperformedby in-
fection or transfection (Table 3). The v-Ha-ras retroviral
recombinant was introduced into BEAS-2B (127),
whereas c-myc and c-rafsequences were transfected via
strontium phosphate precipitation (110). The infected or
transfected BEAS-2B underwent a selection for geneti-
cinresistancepriorto inoculationinto nudemice, withthe
exception of Ki-ras infected cells. v-Ha-ras or v-Ki-ras
gave rise to tumors in a high frequency (Table 3) within
3 to 6weekswiththe followingcharacteristics: very simi-
larmorphology, transplantability, humanorigin, anaplas-
tic carcinomas, increased ploidy and expression of T-
antigen (127).
Interestingly, both the v-Ha-ras infectants and tumor
cell lines established from v-Ha-ras- or v-Ki-ras-induced
tumors were notonlyresistant tobut were stimulatedby
serum, a characteristic that had been previously shown
forcellsisolatedfromhumantumors. c-raforc-myc alone
were not sufficient to induce tumors in nude mice,
whereas the combination ofc-rafand c-myc was tumori-
genic with an incidence of5/8 animals (A. M. A. Pfeifer,
G. E. Mark, and C. C. Harris, unpublished data, Table 3).
These tumors were classified as undifferentiated carci-
nomas and were ofhuman origin. Experiments examin-
ingthe response ofc-raflc-myc tumor cells to inducers of
squamous differentiation are being performed.
Our data to date strongly support the hypothesis that
uncoupling of terminal squamous differentiation and
proliferation pathways are involved in the generation of
neoplasms. The tumorigenic BEAS-2B transfectants
testedacquireresistance to differentiationinducers. How-
ever, loss ofresponse to differentiation-inducing agents is
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Table 3. Effects of (proto)oncogenes on tumorigenicity of T-antigen gene containing human bronchial epithelial cells (BEAS-2B).
Plasmid (Proto)oncogene Mode Tumorigenicity Latency, weeks
Zip neo Transfection/infection 0/22 NA
Zip neo-v-Ha-rasa v-Ha-ras Infection 12/15 3
KiSV v-Ki-ras Infection 4/7 6
Zip neo-c-myc c-myc Transfection 0/10 NA
Zip neo-c-raf c-raf Transfection 0/10 NA
Zip neo-c-myc c-myc Transfection 5/8 4
Zip neo-c-raf c-raf
aThe infection of BEAS-2B with the Zip neo-v-Ha-ras recombinant virus has beendescribed elsewhere(127). The Ki-ras retrovirus required ba-
boon endogenous virus as ahelper cell line. The Zip neo-c-myc plasmid consisted ofafull length murine c-DNA cloned into Zip neo SV(X) (31). Zip
neo-c-rafwas generated by cloningthe full length c-DNA ofthe c-rafgene resected at the 5' end by 39 nucleotides into Zip neoSV(X) (126, A. M. A.
Pfeifer, G. E. Mark, C. C. Harris, unpublished data).
insufficient for tumorigenicity as serum-resistant sub-
clones ofBEAS-2B have notasyetfonnedtumorsinnude
mice (K. Yang, J. F. Lechner, and C. C. Harris, unpub-
lished observation). This suggests that aberrations in the
pathways of differentiation are cooperating with other
events but are insufficient to cause tumorigenesis.
Thephysiological function oftherasgene family is dif-
ferent from that ofrafand myc, suggesting a dissimilar
modus for transformation. The functional and biochemi-
calhomologiesbetweenp21jr protein andGproteins ar-
gues that p21 protein is involved in signal transduction,
and it has been shown that transforming p21 has very
rapideffects onthephosphoinositol tumoverin some cell
types(128). Constitutive activation ofrasproteincaused
byloss ofGTPase activity, increased association oftrans-
formedp21 andGTPtothebiologicalactivefonnortrans-
formational change of the protein with loss of GTP-
bindingrequirementforactivationmayresultincontinu-
ous signalflowandsubsequentlytotransformation (129).
A cooperative effect ofthe rafandmyc oncogenes has
been described in other systems. Both v-myc and v-raf
genes mustbe expressed to induce continuous prolifera-
tion of murine bone marrow cells (130). Infection of
interleuldn-3(IL-3)responsive murinebonemarrowcells
withv-rafinducedtheircontinuous invitroproliferation,
whereasv-mycinfection causedindependenceofthe IL-3
requirement(131). Itmaybe speculatedthatv-mycrepro-
gramsthe cells, whereasv-rafactsasaprimaryoncogene
that efficiently induces the cells to proliferate. This
hypothesis is consistentwith the observationthattumor
celllinesestablishedfromraflmyctransfectedBEAS-2B
cells require conditioned medium for sufficient growth,
suggesting the secretion of an autocrine factor. In this
context, ithasbeen shownthattheintroductionofras or
myc oncogenes intovariouscelltypesresults inthesecre-
tion ofTGF-a (132,133) and that expression ofTGF-a in-
duces transformation ofratfibroblasts(134). Inaddition,
manyhuman small celllungcarcinomalineswithmycam-
plification and rafover-expression produce the mitogen
bombesin, which is growth stimulating for these tumor
cells and also for NHBE cells (135). Further studies are
requiredtodeterminethebiochemicalandbiologicalchar-
acterofthefactor(s)releasedbythe NHBEtransfectants
and their correlation to transformation. It also remains
to be clarified if the presence of SV40 T-antigen se-
quences canmodulate effectsofthetransfectedoncogenes
and if the results of our transformation studies on
BEAS-2B cells can begeneralized for epithelial cells de-
rived from different donors.
Conclusion
Themultistage process ofcarcinogenesis isoften asso-
ciatedwith alteredexpression ofdifferentiated functions,
and we have found that oncogenic agents can cause dis-
orders ofmechanisms regulatingterminal differentiation.
We have shown that serum, TlGF-pl, tumor promoters,
tobacco smoke condensate, and aldehydes induce squa-
mous differentiation ofNHBE cells. The differentiation
process can be dissociated from direct effects of cAMP
and free cytosolic Ca2 + except for aldehydes, where
aldehyde-inducedelevation offreecytosolic Ca2+ maybe
involved inthe formation ofcross-linked envelopes. Induc-
tion ofsquamous differentiation isaccompanied byarapid
induction ofc-fos and reduction ofc-myc steady state in
mRNA levels, suggesting arole ofthese protooncogenes
forsignal transduction. Incontrasttonormalcells, human
lungcarcinoma celllinesarelessresponsive to induction
ofsquamous differentiation by TGF-P, or TPA, and this
decreasedresponsiveness isnotdue tochanges ofrecep-
toraffinityornumber. Carcinogenesis studieswithnickel
sulfate supportthe hypothesis that inhibition ofdifferen-
tiation processes is associated with abberations in pro-
liferationpathways. Theintroduction ofv-Ha-ms orv-Ki-
ras oncogenes and the combination of c-rafand c-nyc
protooncogenes result in transformation of NHBE cells
or SV40 T antigen immortalized BEAS-2B cells. The as-
sociatedresistance to differentiation inducersappears to
be anecessary butinsufficient step inthetransformation
process. Moreover, itmay confer aselected clonal expan-
sion advantage to initiated cells. The elucidation of the
physiologicalroleofprotooncogenes includingtheirpoten-
tial function as growth factors or growth factor activat-
ing agents will help to understand the interactions be-
tween pathways controlling differentiation and
proliferation.
The Ki-ras retrovirus was agiftfromJohn Rhim, Laboratory ofCel-
lular and Molecular Biology, National Cancer Institute.
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